Identification of a Druggable Pathway Controlling Glioblastoma Invasiveness
Nora Pencheva(The Netherlands Cancer Institute), René Bernards(The Netherlands Cancer Institute), Lodewyk F.A. Wessels(The Netherlands Cancer Institute), Tom Würdinger(Harvard University), Daniël J. Vis(The Netherlands Cancer Institute), Mark C. de Gooijer(Manchester Academic Health Science Centre), Olaf van Tellingen(The Netherlands Cancer Institute)
Cited by 68
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k